Snowball logo
logo
1404

Mezzion Pharma Co.Ltd

140410 β€’ KQ
β‚©67,800.00β‚©0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
26,653.930,726.231,720.98,611.67,909.57,971.8
COGS
22,955.631,039.627,836.56,701.36,457.26,520.4
Gross Profit
3,698.3(313.4)3,884.41,910.31,452.31,451.4
Operating Expenses & Income
Operating Income
(16,797.6)(23,331.3)(14,337.9)(14,299.6)(16,768.5)(13,925.3)
Total Operating Expenses
43,451.454,057.546,209.522,911.224,67821,897
R&D Expenses
1,9562,2179392941,259.6578.7
Selling General & Admin Expenses
11,807.914,925.612,272.111,585.210,807.312,271.3
Earnings from Continuing Operations
Interest Expense
(323.4)(423.4)(315.5)(300.8)(1,571.9)(2,234.3)
Interest Income
3,682.43,516.42,158.11,417.3622518.6
Income Tax Expense
577.1-----
Net Income
Net Income
(13,602.7)(36,297.8)(12,728.4)(19,476.8)(34,928.9)(36,927.7)
Supplemental
EBIT
(16,797.6)-----
EBITDA
------
In millions of KRW, except % and values per 1 share